Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequencing CBT for Child Anxiety
NCT01977729Phase 2Terminated
- Sponsor
- Yale University
- Start
- Oct 2013
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sertraline in generalized anxiety disorder (GAD), Social Anxiety Disorder (SAD), separation anxiety disorder (SAD), sponsored by Yale University. Started Oct 2013; status: terminated.
02
Drugs
sertraline
03
Conditions
generalized anxiety disorder (GAD)Social Anxiety Disorder (SAD)separation anxiety disorder (SAD)
Beyond the preview
Go deeper on NCT01977729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01977729.